SPCX heads into the final days of September caught in a genuine tug-of-war: short interest at a six-week high, the stock up 7.8% on the week, and neither side showing any sign of capitulating.
The short-side story keeps getting more compressed. Estimated short shares climbed again on September 22, reaching 191.2 million — 29.9% of the free float and the highest reading since the post-IPO peak campaign in early August. The rebuild from the August 24 trough of 16.9% has been relentless: shorts have recovered roughly two-thirds of their lost ground in under a month, and the one-week jump of nearly 29% in shares short is the most aggressive weekly accumulation in the dataset. What's striking is the context: these positions are being added at prices 13% higher than a month ago. Bears aren't fading into strength — they're leaning into it. The ORTEX short score has risen to 65, its highest reading in two weeks, corroborating the directional conviction on the short side.
The lending market, however, is not backing the bears. Availability has loosened sharply over the same period the position was rebuilt — from 27% in mid-August, when the borrow pool was very tight, to 137% today. That means there are now roughly 1.4 shares available to borrow for every share already lent out, a pool that has more than quadrupled in a month. Cost to borrow is a modest 0.58%, down roughly 26% from levels seen a month ago. For a stock carrying nearly 30% short interest, those are remarkably benign borrow conditions — which matters because it removes a key mechanical pressure that would otherwise force short-side exits. Options positioning has drifted slightly more defensive than usual, with the put/call ratio at 1.07 against a 20-day average of 1.02, but the z-score of 1.46 is not extreme. After touching a one-year high of 1.09 on September 21, the PCR eased back — consistent with the previous note's observation that options traders pulled back from peak defensiveness even as shorts kept adding.
The Street is tilted constructively, but not uniformly. Among 22 buy-rated analysts, the bull case rests on SpaceX's integrated ecosystem — reusable launch as infrastructure, Starlink as recurring revenue, and AI ambitions via Grok and the data flywheel from its operations. Oppenheimer pushed its target to $280 earlier this month; Pivotal Research initiated at Buy with a $220 target on September 8. The bear case, spelled out bluntly, is valuation: a PE north of 118x on trailing earnings, EV/EBITDA near 78x, and a price-to-book above 9x. MoffettNathanson sits at Neutral with a $142 target — below the current price of $154.72 — and raised that target only to $142 from $131 on September 14, a move that reads more as reluctant acknowledgment of price action than fundamental conviction. The spread between the most bullish ($280) and most skeptical ($142) published targets is almost 100% — an unusually wide band that reflects genuine disagreement rather than anchoring to a consensus view.
The ownership picture adds a layer of concentration risk that deserves mention. Elon Musk's 13G filing shows 48.4% of the class, with Google LLC holding 7.2%, Antonio Gracias at 6.5%, and Peter Thiel at 5.5% — all disclosed around the August filing dates. None of the large holders have filed 13D activist notices; all are passive Schedule 13G filers as last disclosed. The bear case prominently flags key-person risk around Musk, and with nearly half the company in one hand, that's not a theoretical risk. Institutional holders beyond the founding cohort — Fidelity, Baron, Sequoia — have all reported fresh or growing positions, suggesting the broader institutional community is still adding around the edges even at current valuation levels. The insider log carries no open-market selling; the April transaction coded as a sale by Musk totaled $1.2 million on 11,390 shares at $105 — trivial relative to his position and likely a tax-related disposition.
Earnings next arrive on November 5. The two prior prints both saw sharp single-day drops — around 8% after the August 5 report and around 5.5% at the prior quarter — before recovering strongly over the following five days, with both five-day moves running above 16% positive. That asymmetric pattern, steep initial drop followed by a meaningful recovery, is the framework shorts appear to be positioning around: the trade is not necessarily a permanent bear view but a bet on a reaction-day flush. How the borrow market behaves as November 5 approaches — whether availability tightens back toward August's stressed levels or remains this loose — will be the clearest read on whether the short setup is intensifying or merely holding its ground.
See the live data behind this article on ORTEX.
Open SPCX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
